Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily data.

COVID-19 D-dimers Fibrinolysis Hemostasis plasma proteins Intensive care unit Thrombin generation Thrombosis

Journal

Data in brief
ISSN: 2352-3409
Titre abrégé: Data Brief
Pays: Netherlands
ID NLM: 101654995

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 01 11 2020
accepted: 06 11 2020
pubmed: 18 11 2020
medline: 18 11 2020
entrez: 17 11 2020
Statut: ppublish

Résumé

This data article accompanies the manuscript entitled: "Prothrombotic Disturbances of hemostasis of Patients with Severe COVID-19: a Prospective Longitudinal Observational Cohort Study" submitted to

Identifiants

pubmed: 33200086
doi: 10.1016/j.dib.2020.106519
pii: S2352-3409(20)31401-3
pmc: PMC7654236
doi:

Types de publication

Journal Article

Langues

eng

Pagination

106519

Informations de copyright

© 2020 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that have or could be perceived to have influenced the work reported in this article.

Références

Crit Care. 2020 Jun 19;24(1):364
pubmed: 32560658
J Thromb Haemost. 2019 Aug;17(8):1273-1287
pubmed: 31063645
J Thromb Haemost. 2018 Jul;16(7):1442-1444
pubmed: 29846034
Int J Lab Hematol. 2020 Oct;42(5):650-660
pubmed: 32426926
Transfus Apher Sci. 2018 Feb;57(1):118-126
pubmed: 29525568
J Thromb Haemost. 2015 Nov;13(11):2119-26
pubmed: 26764429
Thromb Res. 2021 Jan;197:20-23
pubmed: 33161283
Res Pract Thromb Haemost. 2019 Jul 18;3(4):758-768
pubmed: 31624796

Auteurs

Michaël Hardy (M)

Université catholique de Louvain, CHU UCL Namur, Hematology Laboratory, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium.
Université catholique de Louvain, CHU UCL Namur, Anesthesiology Department, Namur Thrombosis and hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium.

Isabelle Michaux (I)

Université catholique de Louvain, CHU UCL Namur, Department of Intensive Care, Yvoir, Belgium.

Sarah Lessire (S)

Université catholique de Louvain, CHU UCL Namur, Anesthesiology Department, Namur Thrombosis and hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium.

Jonathan Douxfils (J)

Department of Pharmacy, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium.
Qualiblood s.a., Namur, Belgium.

Jean-Michel Dogné (JM)

Department of Pharmacy, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium.

Marion Bareille (M)

Université catholique de Louvain, CHU UCL Namur, Hematology Laboratory, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium.

Geoffrey Horlait (G)

Université catholique de Louvain, CHU UCL Namur, Department of Intensive Care, Yvoir, Belgium.

Pierre Bulpa (P)

Université catholique de Louvain, CHU UCL Namur, Department of Intensive Care, Yvoir, Belgium.

Celine Chapelle (C)

Unité de Recherche Clinique, Innovation, Pharmacologie, CHU Saint-Etienne, Hôpital Nord, F-42055 Saint-Etienne, France.
SAINBIOSE U1059, Université Jean Monnet, University Lyon, INSERM, F-CRIN INNOVTE Network, F-42023 Saint-Etienne, France.

Silvy Laporte (S)

Unité de Recherche Clinique, Innovation, Pharmacologie, CHU Saint-Etienne, Hôpital Nord, F-42055 Saint-Etienne, France.
SAINBIOSE U1059, Université Jean Monnet, University Lyon, INSERM, F-CRIN INNOVTE Network, F-42023 Saint-Etienne, France.

Sophie Testa (S)

Haemostasis and Thrombosis Center, Cremona Hospital, Cremona, Italy.

Hugues Jacqmin (H)

Université catholique de Louvain, CHU UCL Namur, Hematology Laboratory, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium.

Thomas Lecompte (T)

Département de Médecine, Hôpitaux Universitaires de Genève, service d'angiologie et d'hémostase et Faculté de Médecine, Geneva Platelet Group (GpG), Université de Genève, Geneva, Switzerland.

Alain Dive (A)

Université catholique de Louvain, CHU UCL Namur, Department of Intensive Care, Yvoir, Belgium.

François Mullier (F)

Université catholique de Louvain, CHU UCL Namur, Hematology Laboratory, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium.

Classifications MeSH